
51 - 200 employees
Founded 2017
🧬 Biotechnology
🏥 Healthcare
💊 Pharmaceuticals
Biotechnology • Healthcare • Pharmaceuticals
Cabaletta Bio is a clinical-stage biotechnology company developing engineered T cell therapies to treat autoimmune diseases. Using its CABA® (Cabaletta Approach to B cell Ablation) platform, the company is advancing rese-cel, a fully human CD19 CAR T cell candidate with a 4-1BB co-stimulatory domain, in multiple RESET™ Phase 1/2 trials for systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris. Cabaletta aims to deliver deep, durable, potentially curative responses by transiently eliminating B cells to reset immune tolerance, and emphasizes patient-centered development and broad indication expansion across rheumatology, dermatology, and neurology.
Selected: 🆕 Date Added.
🕒 October 15
Senior medical writer authoring clinical and regulatory documents for Cabaletta Bio’s engineered T-cell therapies. Supporting global filings, quality control, and cross-functional development programs.
🕒 October 7
Associate Director managing clinical, medical, and regulatory programs for Cabaletta Bio’s autoimmune cell therapies. Coordinating trials, vendors, risks, filings, and enterprise PMO delivery.
🕒 October 6
Senior S&OP manager leading demand, capacity, and inventory planning for Cabaletta Bio’s autoimmune cell therapy programs. Aligning clinical, manufacturing, financial, and regulatory stakeholders.
🕒 September 1
Sr. Manager overseeing cryogenic packaging and labeling for Cabaletta Bio’s autoimmune cell therapies. Ensuring compliant chain of identity and custody across global CDMO networks.
🕒 August 18
Senior Clinical Research Associate supporting Cabaletta Bio’s autoimmune cell therapy trials. Overseeing sites, CROs, vendors, documentation, monitoring, and inspection readiness.
🕒 August 8
Logistics Coordinator managing patient-specific shipments for Cabaletta Bio, a biotechnology company developing cellular therapies for autoimmune diseases. Tracking transportation milestones, documentation, compliance, and escalations across the cell and gene therapy supply chain.
🕒 August 6
Medical writing manager supporting Cabaletta Bio’s engineered T-cell therapies for autoimmune diseases. Producing clinical and regulatory documents, ensuring quality, and mentoring technical writers.
🕒 August 6
Associate Director auditing GxP quality systems for Cabaletta Bio’s autoimmune cell therapies. Leading audits, investigations, CAPA, and compliance improvements across clinical and laboratory operations.
🕒 August 5
Associate Director leading end-to-end clinical data management for Cabaletta Bio’s autoimmune cellular therapy trials. Overseeing data quality, CROs, regulatory submissions, database locks, and clinical study standards.